Agnes Bosch

8PUBLICATIONS
15CO-AUTHORS
Molecular targetsAutonomic nervous systemRespiratory diseasesCardiology (incl. cardiovascular diseases)Genome structure and regulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 24, 2026
Treatment with dapagliflozin and empagliflozin reduces concentrations of N4-acetylcytidine in plasma, a biomarker associated with vascular damage.

|Jul 08, 2025
Effect of renal denervation on glucose metabolism in hypertensive patients with and without chronic kidney disease.

Venera Bytyqi, Dennis Kannenkeril, Axel Schmid

|Jun 27, 2025
Renal denervation increases capillary density in hypertensive patients.

Agnes Bosch, Joanna M Harazny, Axel Schmid

|Jun 10, 2025
Renal denervation is effective in reducing blood pressure in patients with CKD.

Agnes Bosch, Dennis Kannenkeril, Roland E Schmieder

|Nov 21, 2024
Response of Blood Pressure to Renal Denervation Is Not Associated With Genetic Variants.

Christian Delles, Roland E Schmieder, Rónán Daly

|Jan 08, 2024
Blood pressure reduction after renal denervation in patients with or without chronic kidney disease.

Merve Günes-Altan, Axel Schmid, Christian Ott

Pageof 2

Frequent Collaborators

1 joint publications

Roland E Schmieder

1 joint publications

Christian Delles

1 joint publications

Lucas Lauder

1 joint publications

Michael Kunz